High frequency of BRCA1/2 germline mutations in 42 Belgian families with a small number of symptomatic subjects

Por Goelen, G, Teugels, E, Bonduelle, M, Neyns, B, De Greve, J
Publicado em 1999

Enophthalmos as a rare manifestation of metastatic orbital involvement.

Por de Keyser, J., Bruyland, M., de Greve, J., Bernheim, J., Ebinger, G.
Publicado em 1985

Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector

Por Vermeij, J, Zeinoun, Z, Neyns, B, Teugels, E, Bourgain, C, De Grève, J
Publicado em 2001

L-myc cooperates with ras to transform primary rat embryo fibroblasts.

Por Birrer, M J, Segal, S, DeGreve, J S, Kaye, F, Sausville, E A, Minna, J D
Publicado em 1988

Durable remission of inoperable liver metastasis from rectal cancer after hepatic arterial infusion of oxaliplatin and 5-fluorouracil in combination with intravenous cetuximab

Por Van Bael, K., Aerts, M., de Ridder, M., de Gréve, J., Delvaux, G., Neyns, B.
Publicado em 2011

The human L-myc gene encodes multiple nuclear phosphoproteins from alternatively processed mRNAs.

Por De Greve, J, Battey, J, Fedorko, J, Birrer, M, Evan, G, Kaye, F, Sausville, E, Minna, J
Publicado em 1988

Structure and expression of the human L-myc gene reveal a complex pattern of alternative mRNA processing.

Por Kaye, F, Battey, J, Nau, M, Brooks, B, Seifter, E, De Greve, J, Birrer, M, Sausville, E, Minna, J
Publicado em 1988

The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation

Por Sermijn, E, Goelen, G, Teugels, E, Kaufman, L, Bonduelle, M, Neyns, B, Poppe, B, De Paepe, A, De Greve, J
Publicado em 2004

An Observational Study of the First Experience with Bevacizumab for the Treatment of Patients with Recurrent High-Grade Glioma in Two Belgian University Hospitals

Por Huylebrouck, M., Lv, S., Duerinck, J., Van Binst, A., Salmon, I., De Greve, J., De Witte, O., Luce, S., Michotte, A., D'Haens, J., Neyns, B.
Publicado em 2012

A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families

Por Peelen, T., van Vliet, M., Petrij-Bosch, A., Mieremet, R., Szabo, C., van den Ouweland, A. M. W., Hogervorst, F., Brohet, R., Ligtenberg, M. J. L., Teugels, E., van der Luijt, R., van der Hout, A. H., Gille, J. J. P., Pals, G., Jedema, I., Olmer, R., van Leeuwen, I., Newman, B., Plandsoen, M., van der Est, M., Brink, G., Hageman, S., Arts, P. J. W., Bakker, M. M., Willems, H. W., van der Looij, E., Neyns, B., Bonduelle, M., Jansen, R., Oosterwijk, J. C., Sijmons, R., Smeets, H. J. M., van Asperen, C. J., Meijers-Heijboer, H., Klijn, J. G. M., de Greve, J., King, M.-C., Menko, F. H., Brunner, H. G., Halley, D., van Ommen, G.-J. B., Vasen, H. F. A., Cornelisse, C. J., van 'tVeer, L. J., de Knijff, P., Bakker, E., Devilee, P.
Publicado em 1997